Kirima Kazuyoshi, Tsuchiya Koichiro, Sei Hiroyoshi, Hasegawa Toyoshi, Shikishima Michiyo, Motobayashi Yuki, Morita Kyoji, Yoshizumi Masanori, Tamaki Toshiaki
Department of Pharmacology, The University of Tokushima School of Medicine, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.
Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H589-96. doi: 10.1152/ajpheart.01010.2002. Epub 2003 Mar 27.
The measurement of hemoglobin-nitric oxide (NO) adduct (HbNO) in whole blood by the electron paramagnetic resonance (EPR) method seems relevant for the assessment of systemic NO levels. However, ceruloplasmin and unknown radical species overlap the same magnetic field as that of HbNO. To reveal the EPR spectrum of HbNO, we then introduced the EPR signal subtraction method, which is based on the computer-assisted subtraction of the digitized EPR spectrum of HbNO-depleted blood from that of sample blood using the software. Rats were treated with N(omega)-nitro-L-arginine methyl ester (L-NAME; 120 mg. kg-1. day-1) for 1 wk to obtain HbNO-depleted blood. When this method was applied to the analysis of untreated fresh whole blood, the five-coordinate state of HbNO was observed. HbNO concentration in pentobarbital-anesthetized rats was augmented (change in [HbNO] = 1.6-5.5 microM) by infusion of L-arginine (0.2-0.6 g/kg) but not D-arginine. Using this method, we attempted to evaluate the effects of temocapril on HbNO dynamics in an L-NAME-induced rat endothelial dysfunction model. The oral administration of L-NAME for 2 wk induced a serious hypertension, and the HbNO concentration was reduced (change in [HbNO] = 5.7 microM). Coadministration of temocapril dose dependently improved both changes in blood pressure and the systemic HbNO concentration. In this study, we succeeded in measuring the blood HbNO level as an index of NO by the EPR HbNO signal subtraction method. We also demonstrated that temocapril improves abnormalities of NO dynamics in L-NAME-induced endothelial dysfunction rats using the EPR HbNO signal subtraction method.
采用电子顺磁共振(EPR)方法测定全血中血红蛋白 - 一氧化氮(NO)加合物(HbNO),似乎与评估全身NO水平相关。然而,铜蓝蛋白和未知自由基物种与HbNO处于相同的磁场。为了揭示HbNO的EPR光谱,我们引入了EPR信号减法方法,该方法基于使用软件从样品血的数字化EPR光谱中计算机辅助减去HbNO耗尽血的EPR光谱。用N(ω)-硝基 - L - 精氨酸甲酯(L - NAME;120 mg·kg⁻¹·d⁻¹)处理大鼠1周以获得HbNO耗尽血。当将该方法应用于未处理的新鲜全血分析时,观察到了HbNO的五配位状态。通过输注L - 精氨酸(0.2 - 0.6 g/kg)而非D - 精氨酸,戊巴比妥麻醉大鼠的HbNO浓度增加([HbNO]变化 = 1.6 - 5.5 μM)。使用该方法,我们试图评估替莫卡普利对L - NAME诱导的大鼠内皮功能障碍模型中HbNO动力学的影响。口服L - NAME 2周可导致严重高血压,且HbNO浓度降低([HbNO]变化 = 5.7 μM)。联合给予替莫卡普利剂量依赖性地改善了血压变化和全身HbNO浓度。在本研究中,我们通过EPR HbNO信号减法方法成功地将血液HbNO水平作为NO的指标进行了测量。我们还证明了使用EPR HbNO信号减法方法,替莫卡普利可改善L - NAME诱导的内皮功能障碍大鼠中NO动力学的异常。